| Product Code: ETC5359046 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Netherlands continues to see significant growth in buprenorphine import shipments, with top exporting countries in 2024 including Switzerland, Spain, Italy, China, and the USA. Despite moderate concentration indicated by the HHI, the compound annual growth rate (CAGR) from 2020 to 2024 is an impressive 37.54%, with a particularly strong growth rate of 78.15% from 2023 to 2024. This trend suggests a growing demand for buprenorphine in the Netherlands market, potentially driven by various factors such as healthcare needs and regulatory changes.

In the Europe region, the Buprenorphine market in Netherlands is projected to expand at a stable growth rate of 0.00% by 2027. The largest economy is Germany, followed by United Kingdom, France, Italy and Russia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Buprenorphine Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Buprenorphine Market - Industry Life Cycle |
3.4 Netherlands Buprenorphine Market - Porter's Five Forces |
3.5 Netherlands Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Netherlands Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Netherlands Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of buprenorphine therapy for opioid addiction treatment |
4.2.2 Rising prevalence of opioid use disorders in the Netherlands |
4.2.3 Government initiatives promoting the use of buprenorphine over other opioid treatments |
4.3 Market Restraints |
4.3.1 Stringent regulations and monitoring for prescribing buprenorphine |
4.3.2 Stigma associated with opioid addiction treatment |
4.3.3 Limited access to healthcare services for individuals seeking buprenorphine treatment |
5 Netherlands Buprenorphine Market Trends |
6 Netherlands Buprenorphine Market Segmentations |
6.1 Netherlands Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Netherlands Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Netherlands Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Netherlands Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Netherlands Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Netherlands Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Netherlands Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Netherlands Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Netherlands Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Netherlands Buprenorphine Market Import-Export Trade Statistics |
7.1 Netherlands Buprenorphine Market Export to Major Countries |
7.2 Netherlands Buprenorphine Market Imports from Major Countries |
8 Netherlands Buprenorphine Market Key Performance Indicators |
8.1 Percentage of healthcare professionals trained in buprenorphine prescribing practices |
8.2 Number of opioid addiction treatment centers offering buprenorphine therapy |
8.3 Patient retention rates in buprenorphine treatment programs |
8.4 Average wait times for individuals seeking buprenorphine treatment |
8.5 Rate of successful outcomes in buprenorphine therapy programs |
9 Netherlands Buprenorphine Market - Opportunity Assessment |
9.1 Netherlands Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Netherlands Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Netherlands Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Buprenorphine Market - Competitive Landscape |
10.1 Netherlands Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |